| abstract |
'' antibodies to entpd2, combination therapies and methods for using antibodies and combination therapies ''. the present invention relates to antibodies or antigen-binding fragments thereof, for example, monoclonal antibodies or antigen-binding fragments thereof, which specifically bind to entpd2 (e.g., human entpd2 protein), and methods for using those antibodies or antigen-binding fragments thereof. the present invention also relates to combination therapies that comprise an anti-human entpd2 antibody or antigen binding fragment and at least one additional therapeutic agent and method for using such combination therapies. |